Intravesicular taxane-induced dermatotoxicity in a 78-year-old man with urothelial carcinoma and primary cutaneous anaplastic large cell lymphoma.

Journal of Cutaneous Pathology
Daniel J PelletierVincent Liu

Abstract

Patients treated with intravesical bacillus Calmette-Guérin therapy for urothelial carcinoma often become refractory and experience recurrent disease, thus necessitating alternative intravesical treatment modalities if the patient is to be spared the morbidities associated with radical cystectomy. Intravesical treatment with taxane-based chemotherapy, such as docetaxel, has gained traction in urologic oncology, proving to be an effective salvage therapy in such patients. Systemic taxane-based chemotherapeutic regimens have long been used in several advanced malignancies, and their systemic side-effects and associated histologic correlates have been extensively documented. In contrast to adverse effects associated with systemic administration, intravesical taxane administration has thus far proven to be well-tolerated, with little to no systemic absorption. To our knowledge, features of taxane-induced systemic effects have not been reported in this setting. Herein, we report a case of a patient with recurrent urothelial carcinoma treated with intravesical docetaxel, along with primary cutaneous anaplastic large cell lymphoma, who developed characteristic dermatotoxic histologic findings associated with intravenous taxane adminis...Continue Reading

References

Apr 1, 1992·The Journal of Urology·H W HerrH F Oettgen
Apr 13, 1995·The New England Journal of Medicine·E K Rowinsky, R C Donehower
Jan 1, 1997·Cancer Chemotherapy and Pharmacology·D SongJ L Au
Dec 8, 2000·International Journal of Gynecological Pathology : Official Journal of the International Society of Gynecological Pathologists·J A IrvingC B Gilks
Apr 16, 2002·The British Journal of Dermatology·A KaramG Guillet
Jun 29, 2002·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·S P DourakisN Stavrianeas
Jul 10, 2004·Archives of Gynecology and Obstetrics·Christina Moisidis, Volker Möbus
Apr 25, 2006·Journal of Cutaneous Pathology·Stephen E MasonAnne E Wilkerson
Jul 1, 2006·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·James M McKiernanMitchell C Benson
Feb 28, 2008·The American Journal of Surgical Pathology·Jason A DanielsElizabeth Montgomery
Aug 30, 2008·Journal of Oncology Pharmacy Practice : Official Publication of the International Society of Oncology Pharmacy Practitioners·Lita Chew, Vivianne Shih Lee Chuen
May 21, 2009·Journal of the European Academy of Dermatology and Venereology : JEADV·Y SawadaY Tokura
Apr 20, 2011·Journal of the American Academy of Dermatology·Rebecca S Plummer, Christopher R Shea
Nov 23, 2012·Journal of Cutaneous Pathology·Elena GalloAmaro García-Diez
Mar 13, 2013·Journal of Oncology Pharmacy Practice : Official Publication of the International Society of Oncology Pharmacy Practitioners·Christy S HarrisAlison Carulli
May 21, 2013·Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer·Ming J PoiRobert Wesolowski
Dec 5, 2013·Anti-cancer Drugs·David Kudlowitz, Franco Muggia
Apr 18, 2014·Clinical Reviews in Allergy & Immunology·Matthieu Picard, Mariana C Castells
May 16, 2015·Journal of Chemotherapy·Dana BielopolskiFrancis Salamon
Aug 25, 2015·The Journal of Dermatology·Mizue FujiiAkemi Ishida-Yamamoto
Nov 13, 2015·Journal of the European Academy of Dermatology and Venereology : JEADV·L Prieto-TorresL Requena
Oct 30, 2016·European Journal of Dermatology : EJD·Vincent SibaudMario E Lacouture
Sep 8, 2016·The Journal of Dermatology·Tatsuya OgawaManabu Fujimoto

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.

Related Papers

Progress in Clinical and Biological Research
G R Prout
Irish Journal of Medical Science
B LittleR Convery
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
James M McKiernanMitchell C Benson
© 2022 Meta ULC. All rights reserved